Funds holding Solid Biosciences Inc
ISIN US83422E2046 · United States
- Fund holders
- 124
- Of which ETFs
- 24 100 other funds
- Value held
- ≈ 101.3M $ 101.3M $ · 81.6K €
- Share of capital
- 13.6 % of 107.2M shares on Aug 4, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 2,475 | 18K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 2,409 | 17.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 2,054 | 14.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 1,903 | 13.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,875 | 11.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,639 | 11.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity Fund American Century ETF Trust | 1,579 | 9.8K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,578 | 11.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,500 | 10.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,330 | 9.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 957 | 6.9K $ | 0.00 % | as of Apr 30, 2026 ↗ | |
| ULTRA SMALL CAP PROFUND ProFunds | 666 | 4.8K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 372 | 2.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 298 | 2.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 197 | 1.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 149 | 1.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 138 | 993.6 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 108 | 784.1 $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 82 | 590.4 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 60 | 372.6 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 58 | 417.6 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 17 | 105.6 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 16 | 115.2 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 81.6K € | 0.61 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.88 % | as of Apr 30, 2026 ↗ |
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 0.61 % | as of Dec 31, 2025 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 0.46 % | as of Apr 30, 2026 ↗ |
| Columbia Variable Portfolio - Small Company Growth Fund COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.37 % | as of Mar 31, 2026 ↗ |
| Columbia Small Cap Growth Fund COLUMBIA FUNDS SERIES TRUST I | 0.29 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 0.26 % | as of Apr 30, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 0.21 % | as of Feb 28, 2026 ↗ |
| Small Company Value Portfolio Wilshire Mutual Funds Inc | 0.09 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.09 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.09 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 123 | +12 | 14,626,666 | +27.5 % |
| 2026Q1 | 111 | +1 | 11,474,343 | -4.8 % |
| 2025Q4 | 110 | +4 | 12,059,171 | +0.7 % |
| 2025Q3 | 106 | -7 | 11,975,685 | +34.1 % |
| 2025Q2 | 113 | +1 | 8,928,488 | +127.8 % |
| 2025Q1 | 112 | +2 | 3,918,805 | +11.5 % |
| 2024Q4 | 110 | +63 | 3,513,298 | +41.7 % |
| 2024Q3 | 47 | +22 | 2,480,012 | +66.3 % |
| 2024Q2 | 25 | +3 | 1,490,874 | +171.8 % |
| 2024Q1 | 22 | 0 | 548,443 | +25.1 % |
| 2023Q4 | 22 | 438,497 |
Institutional managers
141 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 11,906,646 | 85.7M $ | as of Mar 31, 2026 |
| Bain Capital Life Sciences Investors, LLC | 9,808,819 | 70.6M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 9,339,978 | 67.2M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 7,690,405 | 55.4M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 5,000,000 | 36M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 4,958,354 | 35.7M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 4,010,695 | 28.9M $ | as of Mar 31, 2026 |
| FMR LLC | 3,606,404 | 26M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 3,565,062 | 25.7M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 3,200,000 | 23M $ | as of Mar 31, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,674,624 | 19.3M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 2,596,800 | 18.7M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 2,438,849 | 17.6M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 2,280,125 | 16.4M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,192,937 | 15.8M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 2,050,843 | 14.8M $ | as of Mar 31, 2026 |
| Redmile Group, LLC | 2,011,895 | 14.5M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,756,506 | 12.6M $ | as of Mar 31, 2026 |
| Monashee Investment Management LLC | 1,420,295 | 10.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,295,984 | 9.3M $ | as of Mar 31, 2026 |
| Nantahala Capital Management, LLC | 1,165,078 | 8.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,125,487 | 8.1M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 956,135 | 6.9M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 935,535 | 6.7M $ | as of Mar 31, 2026 |
| Ally Bridge Group (NY) LLC | 766,974 | 5.5M $ | as of Mar 31, 2026 |
Declared shareholders of Solid Biosciences Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RA Capital Management, L.P. and 3 others | 11.90 % | 12,036,126 | as of Jun 22, 2026 · SCHEDULE 13D |
| Invus Public Equities, L.P. and 7 others | 9.99 % | 10,066,682 | as of Mar 31, 2026 · SCHEDULE 13G |
| BlackRock, Inc. | 4.70 % | 4,578,650 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Solid Biosciences Inc". https://titelia.com/en/stocks/solid-biosciences-inc-US83422E2046